Company intelligence / Profile preview

Biodor

Tel Aviv, Israel

Ownership: Private
Development stage: Other

Overview

Biodor Ltd. was an Israeli biotechnology company that specialized in the development of microbiological solutions for oral health and respiratory conditions. The company's primary focus was on treating halitosis (bad breath) and snoring through the use of specific microbial formulations designed to neutralize odor-producing bacteria. Their lead product, also named Biodor, utilized a probiotic-like approach to restore oral flora balance. While the company was active in the late 1990s and early 2000s, it is currently considered inactive in the pharmaceutical development space.

Therapeutic areas: PulmonologyGastroenterology
Modalities: Microbial therapyDevice
Industry: Biotech

Beyond the preview

Go deeper on Biodor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biodor.

Explore the full profile